Plano-based AllerVie Health announced that Tae Kim will be the new chief executive officer of the national network of allergy clinics.
Kim’s promotion from president reflects the company’s strategic plan, AllerVie said.
Chris Roussos, executive chairman of the board and former chief executive officer, will continue in his role on AllerVie’s board as executive chairman, where he remains actively engaged in key strategic activities on behalf of the company, AllerVie said.
“I’ve had the privilege of working with and mentoring Tae since we partnered for the incredibly successful sale of Epic Health Services in 2016. His exemplary leadership, invaluable strategic insight, and unwavering commitment to our mission of improving healthcare services have been instrumental in establishing our position as a frontrunner in the allergy and asthma industry,” Roussos said in a statement.
“Collaborating with Tae, I’ve seen firsthand how his understanding of the industry and ability to structure meaningful partnerships between physicians, the allergy community, and our organization have been critical to our success.”
‘Positive change’ in the allergy industry
Kim joined AllerVie as chief operating officer in 2021 and has focused extensively on aligning physicians’ goals with AllerVie’s growth strategies and creating partnerships designed to forward the objectives of both clinicians and patients, the company said.
Kim’s approach has propelled AllerVie from nine clinics and eight physicians in 2020 to nearly 80 clinics and 100 providers by the end of 2023, AllerVie said.
Before AllerVie, Kim was the chief operating officer and chief financial officer at Martin UAV, an aerospace technology company.
That company experienced significant growth under his leadership, culminating in a successful acquisition by Shield AI, a leading AI defense technology company.
Kim began his career in healthcare in investment banking at Goldman Sachs, focusing on healthcare mergers & acquisitions, equity raises, debt financing, and corporate advisory.
“Over the last three and a half years, Chris has laid an incredible foundation expanding AllerVie’s nationwide footprint, focusing our overarching objectives, and establishing the vision and team to execute AllerVie’s impact on allergy, asthma, and immunology on a national scale,” Kim said in a statement.
“I’m looking forward to taking on the role as CEO and continuing AllerVie’s mission to redefine care and access in this specialty, setting new standards in healthcare excellence and innovation to exceed patient expectations. As Chris always does, he’s built a world-class team at AllerVie. I am honored to continue working with him in our new roles to advance the experience and propel positive change for our patients, physicians, and the allergy industry.”
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.